Literature DB >> 14481816

Reduction of serum-lipid and uric-acid levels by an orally active androsterone.

M F OLIVER.   

Abstract

Entities:  

Keywords:  ANDROGENS/therapy; CHOLESTEROL/blood; LIPIDS/blood; MYOCARDIAL INFARCT/therapy; URIC ACID/blood

Mesh:

Substances:

Year:  1962        PMID: 14481816     DOI: 10.1016/s0140-6736(62)92422-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  EFFECT OF CLOFIBRATE AND ANDROSTERONE ON HYPERCHOLESTEROLAEMIC XANTHOMATOSIS.

Authors:  B MASON; C B PERRY
Journal:  Br Med J       Date:  1965-01-09

2.  IDIOPATHIC LIPAEMIA RETINALIS.

Authors:  J F CULLEN; W D CONACHER
Journal:  Br J Ophthalmol       Date:  1965-01       Impact factor: 4.638

3.  The clofibrate saga: a retrospective commentary.

Authors:  Michael Oliver
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

4.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

5.  Effect of clofibrate on cholesterol metabolism in rats treated with polychlorinated biphenyls.

Authors:  M Nakagawa; T Shimokawa; A Noguchi; N Ishihara; S Kojima
Journal:  Lipids       Date:  1986-02       Impact factor: 1.880

6.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Authors: 
Journal:  Br Heart J       Date:  1978-10

7.  Halofenate versus clofibrate in the management of true diabetes insipidus.

Authors:  A Gattereau; J Davignon; M Verdy; W Lewis
Journal:  Can Med Assoc J       Date:  1974-06-08       Impact factor: 8.262

8.  Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease.

Authors:  P Carson; L McDonald; S Pickard; T Pilkington; B Davies; F Love
Journal:  Br Heart J       Date:  1966-05

9.  Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.

Authors: 
Journal:  Br Med J       Date:  1971-12-25

10.  Clofibrate, serum enzymes, and muscle pain.

Authors:  A F Smith; W G Macfie; M F Oliver
Journal:  Br Med J       Date:  1970-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.